Research
Principal Investigators affiliated with the CTO program:
|
Dept |
|
Principal Investigator |
|
Research Area |
|
Surgery |
|
|
The responses in the human body to surgery that stimulate tumor growth or the formation of metastases. |
|
|
|
|
|
Malignant diseases of the upper gastrointestinal tract. |
|
|
|
|
|
Laparoscopic gastro-intestinal and oncological surgery (including robotsurgery). |
|
|
|
|
|
Metastatic colon cancer. |
|
|
|
|
|
Pancreas and liver surgery. |
|
|
|
|
|
Clinical aspects of operations on esophagus and stomach. |
|
|
|
|
|
M.E.N.-syndrome, pituitary gland disorders, Addison’s disease and endocrine autoimmune diseases. |
|
|
|
|
|
Multiple endocrine neoplasia (MEN), thyroid cancer and pancreatic cancer. |
|
|
|
|
|
Hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancy. |
|
| Head and Neck Surgical Oncology | Van Es, R.J.J. |
Individualized treatment and personalized Head Neck cancer care based on Image-guided and Molecular-guided treatment. |
||
|
Pathology |
|
|
How do the granzymes normally kill tumor cells and how can tumor cells escape from the cytotoxic immune response. |
|
| The genetics of cystic preneoplastic pancreatic tumors (IPMN) and the transition to pancreatic carcinoma. | ||||
|
|
|
|
How does loss of cell-cell adhesion lead to tumour progression, with an emphasis on breast cancer. |
|
|
|
|
|
Unraveling the origin of breast cancer optimalization of the diagnostics and treatment of breast cancer. |
|
|
|
|
|
Identification of behavior in early invasive colorectal cancer. |
|
|
|
|
Leng de, W.W.J. |
|
Polyposis and tumorigenesis in Peutz-Jeghers Syndrome. |
|
|
|
|
1) Understanding the molecular mechanisms underlying differential anti-cancer drug sensitivity in breast and ovarian cancer patients in order to develop tests that may guide treatment decisions in the clinic and ultimately improve survival.
|
|
|
|
|
|
Unraveling the genesis of breast cancer and to optimize the diagnostics and treatment of this disease. |
|
|
|
|
|
Unraveling the molecular and genetic mutations that cause cancer in the digestive tract. |
|
|
|
|
|
Molecular Pathology of head and neck carcinoma. |
|
|
MDL |
|
|
Loco-regional treatment of liver malignancies. |
|
|
|
|
|
|
|
|
|
|
Linde ter, Jose |
|
Chemoprevention, early detection, and correct diagnosis of colorectal adenomas and cancer. |
|
|
|
|
Detection and endoscopic treatment of early colorectal cancer. |
|
|
|
|
|
Understanding Crohn’s disease and colitis ulcerosa to offer patients better treatment and a better quality of life. |
|
|
|
|
|
Clinical trials studying new therapeutic endoscopic procedures (i.e. endo-ultrasound pain blockade and transmural drainages, endoscopic (sub)mucosal resections of early gastro-intestinal cancers in the digestive tract and palliative stent placements). | |
|
Gynaecology |
|
|
Ovarian function. |
|
|
|
|
|
Ovarian cancer, (micro)-metastases in cervical cancer and minimal invasive surgery within gynaecological oncology. |
|
|
Radio-therapy |
|
|
Translational imaging in breast oncology: decision support systems for patient tailored therapy selection. |
|
|
|
|
|
Thermal modelling for hyperthermia. |
|
|
Radiology |
|
|
Image-guided treatment of cancer (oncological interventions). |
|
|
|
|
|
Individualized treatment in nuclear oncology and personalized cancer care based on image-guided treatment. |
|
|
Veterinary Medicine |
|
|
Unraveling the mystery of polyploidy in the liver and to discover the mechanism of tumor suppression by atypical E2Fs. |
|
|
|
|
|
Spontaneous cancer in companion animals with special interest in cancer stem cells in mammary cancer, adrenocortical tumors and insulinomas of the dog. |
|
|
Medical Oncology |
|
Langenberg, Marlies en |
|
Phase 1 and 2 studies in cancer patients with solid tumors to explore the safety and tolerance, and sometimes preliminary efficacy of a new medicine. |
|
|
|
|
Colorectal cancer: Phase 3 CAIRO studies of the Dutch Colorectal Cancer Group (DCCG) and observational cohort studies (PICNIC).
Websites: |
|
|
|
|
|
Primary brain tumors. |
|
|
|
|
|
Elucidating cellular and angiogenetic pathways that result in breast cancer (development). |
|
|
Julius Center |
|
|
Epidemiological studies of breast cancer. |
|
|
|
|
|
The additional value of MRI for women with extremely dense breasts in the population-based breast cancer screening program in the Netherlands. |
|
|
|
|
|
Physical activity, obesity and cancer. |
|
|
|
|
|
Molecular end genetic epidemiology of breast- and ovarian cancer. |
|
|
|
|
|
Risk assessment and prevention of cancer with a focus on nutrition, lifestyle, biomarkers and genes.
Websites: |
|
|
Neuro-Oncology |
|
|
Brain tumors with the focus on extracellular vesicles. |
|
|
|
|
|
Resistance mechanisms that are activated in tumor cells as a reaction to therapy. |
|
|
Clinical Chemistry & Haematology |
|
|
Synthetic and natural nanoparticles (~100 nm) for therapy and diagnosis. |
|
|
Translational Immunology |
|
|
Immunomonitoring and immunotherapy.
Websites:
Movies: |
|
|
Molecular Cancer Research |
|
|
Unraveling the molecular principles that ensure faithful chromosome segregation during cell division, to understand how and why the fidelity of this segregation process is disturbed in cancer cells. |
Upcoming
18 November 2022
Translational Immuno Oncology course
21-22-23 November 2022
Quotes course 2021:
"Nice mix of experts in the field"
"The presentations were nicely up to date and gave a nice overview of recent discoveries in the immuno-oncology field"
"Quality was good, usefulness of the practical sessions was great"
"I learned a lot from this course and from time to time I was really challenged. It will help me with future research"